Literature DB >> 5129308

Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases.

H D Ochs, S D Davis, R J Wedgwood.   

Abstract

Immunologic responses to bacteriophage varphiX 174 were studied in 26 patients with immunodeficiency diseases. In eight cases of infantile X-linked agammaglobulinemia, there was prolonged circulation of phage and no detectable antibody response. The remaining 18 patients cleared phage normally and produced antibodies. 10 of these patients made only IgM antibody in spite of repeated immunization; all of these have recurrent respiratory tract infections and require treatment with gamma globulin and antibiotics. Eight patients made both IgM and IgG antibody; they experience either milder or no infections, and only one requires treatment with gamma globulin. Prolonged circulation of bacteriophage varphiX 174 and the absence of a detectable antibody response appear to be distinguishing characteristics of X-linked agammaglobulinemia if severe combined immunodeficiency can be excluded.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5129308      PMCID: PMC292205          DOI: 10.1172/JCI106756

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  The antibody response to bacteriophage phi-X 174 in newborn premature infants.

Authors:  J W UHR; J DANCIS; E C FRANKLIN; M S FINKELSTEIN; E W LEWIS
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

2.  Antibody production by hypogammaglobulinemic patients.

Authors:  S BARON; J P NASOU; R M FRIEDMAN; G M OWEN; H B LEVY; E V BARNETT
Journal:  J Immunol       Date:  1962-04       Impact factor: 5.422

3.  Destruction of some agglutinins but not of others by two sulfhydryl compounds.

Authors:  R GRUBB; B SWAHN
Journal:  Acta Pathol Microbiol Scand       Date:  1958

4.  Bacterial and viral antibodies in patients with hypogammaglobulinaemia.

Authors:  F O MACCALLUM
Journal:  Proc R Soc Med       Date:  1962-05

5.  Suppression of IgM and IgG synthesis in young rabbits by 6-methyl mercaptopurine treatment.

Authors:  H G Herrod; M Myers; K S Self; M D Cooper
Journal:  J Lab Clin Med       Date:  1970-07

6.  Immunoglobulins, antibodies and the bursa of Fabricus: induction of agammaglobulinemia and the loss of all antibody-forming capacity by hormonal bursectomy.

Authors:  N L Warner; J W Uhr; G J Thorbecke; Z Ovary
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

7.  The serum antibody response to bacteriophage phi chi 174 in germ-free and conventionally reared mice. I. Assay of neutralizing antibody by a 50 per cent neutralization method.

Authors:  P W Stashak; P J Baker; B S Roberson
Journal:  Immunology       Date:  1970-02       Impact factor: 7.397

8.  Relationship between molecular size and intra- and extravascular diribution of protein antigens.

Authors:  R M Nakamura; H L Spiegelberg; S Lee; W O Weigle
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

9.  Nodular lymphoid hyperplasia of the small intestine and sarcoidosis.

Authors:  S D Davis; S Eidelman; J W Loop
Journal:  Arch Intern Med       Date:  1970-10

10.  Antibody formation. III. The primary and secondary antibody response to bacteriophage phi X 174 in guinea pigs.

Authors:  J W UHR; M S FINKELSTEIN; J B BAUMANN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

View more
  48 in total

1.  CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.

Authors:  J R Abrams; M G Lebwohl; C A Guzzo; B V Jegasothy; M T Goldfarb; B S Goffe; A Menter; N J Lowe; G Krueger; M J Brown; R S Weiner; M J Birkhofer; G L Warner; K K Berry; P S Linsley; J G Krueger; H D Ochs; S L Kelley; S Kang
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Autoimmunity in the relatives of patients with immunodeficiency diseases.

Authors:  J M Friedman; P J Fialkow; S D Davis; H D Ochs; R J Wedgwood
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

Review 3.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

4.  PhiXing-it, displaying foreign peptides on bacteriophage ΦX174.

Authors:  Kristofer J Christakos; Janice A Chapman; Bentley A Fane; Samuel K Campos
Journal:  Virology       Date:  2015-12-03       Impact factor: 3.616

Review 5.  The molecular basis for T cell help in humoral immunity: CD40 and its ligand, gp39.

Authors:  L S Marshall; A Aruffo; J A Ledbetter; R J Noelle
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

Review 6.  Laboratory diagnosis of primary immunodeficiencies.

Authors:  Bradley A Locke; Trivikram Dasu; James W Verbsky
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

7.  Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy.

Authors:  Olivier Humbert; Frieda Chan; Yogendra S Rajawat; Troy R Torgerson; Christopher R Burtner; Nicholas W Hubbard; Daniel Humphrys; Zachary K Norgaard; Patricia O'Donnell; Jennifer E Adair; Grant D Trobridge; Andrew M Scharenberg; Peter J Felsburg; David J Rawlings; Hans-Peter Kiem
Journal:  Blood Adv       Date:  2018-05-08

8.  Immunologic reconstitution during PEG-ADA therapy in an unusual mosaic ADA deficient patient.

Authors:  Ping Liu; Ines Santisteban; Lauri M Burroughs; Hans D Ochs; Troy R Torgerson; Michael S Hershfield; David J Rawlings; Andrew M Scharenberg
Journal:  Clin Immunol       Date:  2008-10-25       Impact factor: 3.969

9.  Epstein-Barr virus-induced lymphoblastoid cell lines derived from the peripheral blood of patients with X-linked agammaglobulinemia can secrete IgM.

Authors:  D Levitt; H Ochs; R J Wedgwood
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

10.  The immune response to phichi174 in man. IV. Primary and secondary antibody production in patients with chronic lymphatic leukaemia.

Authors:  T J Hamblin; J V Jones; D B Peacock
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.